Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,038,746
-
Share change
-
+1,266,999
-
Total reported value
-
$117,879,171
-
Put/Call ratio
-
32%
-
Price per share
-
$7.35
-
Number of holders
-
109
-
Value change
-
-$23,868,208
-
Number of buys
-
53
-
Number of sells
-
66
Institutional Holders of NEWLINK GENETICS CORP - COM (NLNK) as of Q2 2017
As of 30 Jun 2017,
NEWLINK GENETICS CORP - COM (NLNK) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,038,746 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, COLUMBUS CIRCLE INVESTORS, BAKER BROS. ADVISORS LP, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This page lists
109
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.